New immunology research published in Nature Immunology identifies a lung-resident, monocyte-derived population that supports durable CD8+ T cell memory after influenza infection. The study describes monocyte subsets that persist in the lungs for months and help generate functional memory T cells at the site where viruses initiate infection. The work focuses on monocytes recruited to the lung that differentiate into memory-stage CCR2-tdTomato cells and persist for more than four months post-infection. Tissue-resident memory T cells are positioned to respond rapidly and help limit viral spread, and the authors argue these innate–adaptive interactions may be a design target for next-generation vaccines. The findings address a known gap for many current influenza vaccines, including injected formulations, which do not consistently build airway immunity that prevents initial infection and transmission.